Quoin Pharmaceuticals

QNRX · NASDAQ

$4.04−$0.28 (−6.48%)TodayMarket closed · Oct 21, 4:23 AM ET

Prev close $4.32

Latest news

Press releaseOct 20, 6:30 AM ETGlobe Newswire
Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
NewsOct 14, 6:31 AM ET
Quoin Pharmaceuticals’ Lead Product Candidate QRX003 Granted Orphan Drug Designation By European Medicines Agency For Treatment Of Peeling Skin Syndrome
Press releaseOct 14, 6:30 AM ETGlobe Newswire
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Press releaseOct 6, 6:30 AM ETGlobe Newswire
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
Press releaseSep 22, 8:30 AM ETGlobe Newswire
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Press releaseSep 10, 8:30 AM ETGlobe Newswire
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
Press releaseSep 8, 2:12 PM ETGlobe Newswire
CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
Press releaseSep 8, 8:30 AM ETGlobe Newswire
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
NewsAug 28, 10:09 AM ETAvi Kapoor
Dow Gains 100 Points; Chicago PMI Falls In August
NewsAug 28, 9:40 AM ETHenry Khederian
Quoin Pharmaceuticals Stock Surges Friday: What's Happening?
NewsAug 28, 7:20 AM ET
Market-Moving News for August 28th
Press releaseAug 28, 6:00 AM ETGlobe Newswire
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
Press releaseAug 28, 6:00 AM ETGlobe Newswire
Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome
NewsAug 14, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsJun 24, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsMar 27, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsMar 26, 7:11 AM ET
Earnings Scheduled For March 26, 2026
NewsDec 9, 12:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsDec 5, 7:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsNov 11, 9:40 AM ETAvi Kapoor
US Stocks Mixed; Sea Shares Gain After Q3 Results
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
NewsOct 10, 12:56 PM ETAvi Kapoor
Crude Oil Falls Over 4%; Quoin Pharmaceuticals Shares Spike Higher
NewsOct 10, 12:31 PM ETHenry Khederian
Quoin Pharmaceuticals (QNRX) Stock Is Skyrocketing Friday: What's Going On?
NewsOct 10, 10:23 AM ETAvi Kapoor
Dow Surges 150 Points; US Consumer Sentiment Edges Lower
NewsSep 17, 5:15 AM ETAvi Kapoor
Why New Fortress Energy Shares Are Trading Higher By 41%; Here Are 20 Stocks Moving Premarket
Press releaseSep 9, 8:30 AM ETGlobe Newswire
Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome
Press releaseAug 21, 8:30 AM ETGlobe Newswire
Quoin Pharmaceuticals' NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome
NewsAug 7, 4:33 AM ET
Earnings Scheduled For August 7, 2025
NewsMay 14, 8:09 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsMay 5, 8:07 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsApr 17, 8:09 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsApr 3, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseJan 7, 2:29 PM ETGlobe Newswire
PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials
NewsOct 17, 8:10 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsOct 17, 5:39 AM ETAvi Kapoor
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
NewsSep 10, 6:41 AM ETAvi Kapoor
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy

Quoin Pharmaceuticals’ Lead Product Candidate QRX003 Granted Orphan Drug Designation By European Medicines Agency For Treatment Of Peeling Skin Syndrome

Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome

Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy

Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome

Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU

CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

Dow Gains 100 Points; Chicago PMI Falls In August

Quoin Pharmaceuticals Stock Surges Friday: What's Happening?

Market-Moving News for August 28th

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million

Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Earnings Scheduled For March 26, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

US Stocks Mixed; Sea Shares Gain After Q3 Results

Earnings Scheduled For November 6, 2025

Crude Oil Falls Over 4%; Quoin Pharmaceuticals Shares Spike Higher

Quoin Pharmaceuticals (QNRX) Stock Is Skyrocketing Friday: What's Going On?

Dow Surges 150 Points; US Consumer Sentiment Edges Lower

Why New Fortress Energy Shares Are Trading Higher By 41%; Here Are 20 Stocks Moving Premarket

Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome

Quoin Pharmaceuticals' NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome

Earnings Scheduled For August 7, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket